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MICROBIAL ASSAY OF CYPROFLOXACIN IN A BONE IMPLANT
(cHrTosAN 
-BOVTNE HYDROXYAPATTTE WrrH CROSS-LINKER
G LUTARALD E HYD E ) TOWAR DS Sto p h i I ococcu s o u re u s
ATCC25923
Esti Hendradi, Dewi Melani Hariyadi, Muhammad Faris Adrianto
Faculty of Pharmacy, Universitas Airlangga, Jl. Dharmawangsa Dalam Surabaya 60286.
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INTRODUCTION
Bone is one part of the body has an important role
to support the body's physiological functions (Porter
et al., 2009). Complications of bone diseases and
bone disorders caused by traumatic accidents may
result in a gap (defect) on the bone. The healing
process of damage or fracture is determined by the
level of trauma and soft tissue damage (strobel et
al., 2011). Some cases of damage or injury to the
bone can not undergo natural recovery (Porter et al.,
2009). Therefore, clinical rehabilitation to overcome
the defect on the bone is expected to increase in line
with population growth (Mourino et al., 2010).
Treatment rehabilitation of bone cannot be
separated from the risk of infection complications.
Complications of bacterial infections can be treated
with antibiotics. However, in the case of a crack
(defect) occurs devascularity of bone tissue so that
the delivery of antibiotics to the target tissue to be
blocked. This resulted in the concentration of the
antibiotic to the target so low that it cannot
penetrate the bacteria. The condition can lead to
bacterial resistance to antibiotics (Li et al., 2010). A
high dose of antibiotics in the long term experienced
problems because it can cause systemic toxicity and
side effects (Mourino et a1.,2010). To overcome
these problems, antibiotics can be done locally using
a certain drug delivery systems. The purpose of such
delivery systems is to provide drug concentration in
a specific location and ensure the drug release
profile for a certain time period (Dubnika et al.,
2072). Dtug delivery locally has several advantages,
among others, (a) the systemic effects can be
avoided, (b) the amount of drugs used less and
secure, and (c) the efficacy and efficiency of drug
delivery locally can be achieved (Harmankaya et al.,
2013). Administration of antibiotics locally also to
minimize side effects and risk of toxicity compared
to administration of systemic antibiotics. ln addition,
antibiotics locally also allows conduction in target
tissues with high concentration (Mourino et al.,
2010). The release of antibiotics on the target
network is expected to last continuously for a certain
time and achieve a greater concentration than the
minimum inhibitory concentration {MlC). Drug
delivery systems in a controlled manner (controlled
release system) can help increase the bioavailability
of antibiotics in target tissues. The system is
designed to release the drug at the expected
location at a rate appropriate for a certain time
period (Mourino et a1.,2010). ln a previous study
showed that a good composite is Ciprofloxacin: BHA:
chitosan = 10:30:60. Cross linker with
glutaraldehyde \cAl o.7% and with 10% active
ingredient Ciprofloxacin can release Cyprofloxacin
for 30 days (Hendradi et al, 2015). This research will
be seen potency against Staphilococcus aureus
ATCC25923 Ciprofloxacin for 30 days.
MATERIAI. AND METHODS
Materials
Ciprofloxacin (Shangyu Jingxin Pharmaceutical Co.
Ltd) ; Bovine Hydroxyapatite (BHA) diperoleh dari
Bank Jaringan RSUD DR Soetomo Surabaya; Chitosan
(Biotech lndonesia); glutaraldehid 25% p.a (Merck
Milipore-German); asam asetat glacial p.a (Merck),
Na2HPO4 p.a (Merck), KzHPOT p.a, KH2POa p.a, Nacl
p.a (Merck-German) and Aquabidest
Methods
T.Fomulotion of Bovine Hydrcryopotite - chitosqn-
ciptofloxocii implont
The composition of formulations of implant before
adding glutaraldehyde was mentioned in Table 1.
The implant produced by compression method.
Ciprofloxacin were dissolved in aquabidest, Bovine
Hydroxyapatite added gradually and mixed until
homogen with ciprofloxacin. chitosan powder were
added to ciprofloxacin-Bovine Hydroxyapatite blend
and mixed until homogen. Aquabidest were added
gradually with continous stirring until form wet
granules mass. Wet granules mass were sieved using
1 mm siever and dried overnight (24 hours) at 40 'C
to obtain dried granules. Dried granules were
immersed in glutaraldehyde solution (O.7yo
concentration) for 24 hours until the colour was
change. Granules were washed with aquabidestilata
to remove the residual glutaraldehyde. At the final
stage, granules were washed
100
uith phosphate buffer saline (PBS) pH 7.40. Granules
r€re dried in oven at 40'C for 24 hours. Dried
granules were weighed 100 mg, pressed using tablet
press machine with 4.0 mm diameter and the
s)mpression pressure was 2 tons (Hendradi et al,
201s).
Table 1. The composition of implant formulation
Compound Concentration
l%l
Cyprofloxacin 10
BHA 30
Chitosan 60
2 Releosed Study ol Cyptofloxocin
The release study of cyprofloxacin from implant was
done as sample for test potential. lmplant was
placed in a vial containing 5 ml of phosphate buffer
sline (PBS) pH 7.4. Vial was placed in a shelf and
ircubated in waterbath at 37'C t 0.5 "C. Sampling
U:as conducted by pippeting 1 ml of elution fluids at
Fedetermined time intervals (1, 2,3, until ....30 )
day and replaced with fresh buffer to maintain sink
condition. Appropriate dilution was prepared using
,Sosphate buffer saline (PBS) pH 7.a. The release of
c!)rofloxacin HCL from the implants was determined
ir triplicate using microbial assay.
I Optimizotion oI the minimum inhihitory concentrdtion}tc)
llade six standard solution with a concentration of
cyprofloxacin 0.06 ug/ml - 2 $glml. Cyprofloxacin
qandard solution that has been created is inserted
irto the hole that has formed on nutrient agar,$ich had previously been inoculated with
9aphylococcus aureus ATCC 25923. lncubation for
24 hours at a temperature of 37"C. Observe
d|e inhibition zone is formed. Lowest levels of
-*ribitory zone where there is a minimum inhibitory
@ncentration of cyprofloxacin.
Eure 1. MIC Determination of yiprofloxacin towards
Lphylococcus aureus ATCC 25923
4. Test potency dilution method ol ontibiotic
Test antibiotic poteny dilution method prints holes
(wells) design 3-3. A total of 10 ml of inoculum of
Staphylococcus aureus ATCC 25923 was inserted into
the tube containing the seed layer 8 ml media
Nutrient Agar that had thawed and then allowed to
stand up to a temperature of 45 - 50eC.
Homogenized with a vortex, then poured evenly
over the surface of the base layer has been solidified
in a petri dish, allowed to solidifv. Hole was made in
order to use the printer for sterile. Each hole was
filled with the test solution and standard solution as
50,0U1 for each hole and then incubated at 37eC for
24 hours. Diameter of inhibition zone formed at each
hole was measured by using a caliper. The resulting
inhibition zone diameter compared with the border
of the effective inhibition zone, the minimum range
of 14-16 mm (Depkes R|,2014)
7. lmplont ol cyptofloxocin
2. The Minimdl lnhibitory Concentrction (MIC) oI
cyprofloxdcin
The Minimal lnhibitory Concentration (MlC) of
ciprofloxacin towads Stophylococcus dureus AfCC
25923 was2.0 tE/ml showed in table 2 and Figure 3.
ln figure 3 showed that the MIC of cyprofloxacin was
2.0 [c/ml (U1)
Figure 3.The Minimal lnhibitory Concentration (MlC) of
cyprofl oxacin towa.ds towatds Stophylococcus ou reus
ATCC 25923
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RESULT AND DISCUSSION
The implant formulation showed in figure 2.
Figure 2, lmplantof cyprofloxacin
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Table 2. The Minimal tnhibitory
(MlC) of Cyprofloxacin towards
dureus ATCC 25921
ATCC25923 showed in Figure 5. lt's mean that the
implant formulation of cyprofloxacin had the ability
to against Staphylococcus aureus ATCC25923.
Concentration
Stophylococcus
lt5 ------------------------
Concent
ration
(pclml)
Replication 1 Replication 2 n5
105Zona
lnhibiti
on
Diamet
er of
Zona
lnhibiti
on
Zoaa
tnhibiti
on
Diamet
er of
Zona
lnhibiti
on
9!
+PoLEy ol Cirond.cln 0.7 Ol
--.Lr.l Pot nc, olclFoioEh
2.O + 14.00 +
mm
1.0
0.5
0.25
o.72
0.06
Releqsed Study of Cyprofloxocin
The data of released study was found from the
previous study (Hendradi, et.a1.,2015). ln this data
showed that the concentration of Cyprofloxacin
release every day was in therapeutics level (2-50
pg/ml). lt's showed in figure 4
f hsBpEJlit Cllc J0 srirro
0.00 5.00 10.00 15.00 20.00 25.00 30.00
I)rv
Figure 4. Concentration of cyprofloxacin profil vs time
(day) released from implant BHA-chitosan-ciprofloxacin
0.7% glutaraldehyde in phosphate buffer saline Towards
Staphylococcus aureus ATCC25923 for 30 days, Each
value represents the mean + S.D. of 3 determinations
(Hendradi et al, 2015)
3. Poten.y of Cyptofloxqcin released to Stophilococcus
duteus ATCC 25923
The result showed that the potency of cyprofloxacin
against Staphylococcus aureus ATCC25923 could
meet the requirements for antibiotic microbial assay
that was 80-125%. The results was similar with the
concentration of cyprofloxacin released from
implant (Hendradi, et al., 2015). The results of
cyprofloxacin towards Staphylococcus aureus
14.30
mm
l l 5 7 ta 12 ta la tt 2a 12 2a u r t
Day
15
@
p
!o
d)
.00
.00
&
.00
Figure 5. Potency cyprofloxacin profil vs time (day
released from implant BHA-chitosan-ciprofloxacin
0.7% glutaraldehyde) in phosphate buffer salinc
Towards Staphylococcus aureus ATCC25923 tor :I)
days. Each value represents the mean a S.D. of 3
determinations
coNcruSroN
The result showed that the potency of c.yprofloxacin
in the formula could meet the requirements for
antibiotic microbial assay that was 80-125% to
inhibit the bactetia Stophylococcus aureus AICC
25923 for 30 days.
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